Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price was down 2.2% during mid-day trading on Tuesday . The stock traded as low as $20.44 and last traded at $21.01. Approximately 252,071 shares were traded during trading, a decline of 84% from the average daily volume of 1,541,311 shares. The stock had previously closed at $21.49.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on ACHC shares. StockNews.com downgraded Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. TD Cowen dropped their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Barclays cut shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $43.00 to $35.00 in a research note on Friday, February 28th. Royal Bank of Canada lowered their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Finally, Mizuho lowered their price target on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a report on Tuesday, March 25th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $50.39.
Read Our Latest Research Report on Acadia Healthcare
Acadia Healthcare Stock Down 2.7 %
The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market cap of $1.93 billion, a PE ratio of 6.85, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13. The company has a fifty day moving average of $30.99 and a two-hundred day moving average of $39.43.
Institutional Trading of Acadia Healthcare
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. Wellington Management Group LLP lifted its stake in shares of Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock worth $465,283,000 after acquiring an additional 76,490 shares during the last quarter. FMR LLC boosted its stake in shares of Acadia Healthcare by 257.9% during the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Acadia Healthcare by 18.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after buying an additional 486,395 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after acquiring an additional 454,044 shares during the period. Finally, Madison Avenue Partners LP purchased a new stake in shares of Acadia Healthcare in the fourth quarter valued at approximately $76,339,000.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
